HS
Hyungjin Shin
About Hyungjin Shin
Data last updated:
Hyungjin Shin is a Director at Nuerepa Biotechnology Private Limited (since 2020). The company operates in Healthcare. Nuerepa Biotechnology Private Limited reported revenue of ₹73,835 (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuerepa Biotechnology Private Limited U51909DL2020FTC374559 | Director | 15 Dec 2020 | 2020 | ₹73,835 (FY 2021) | Active |
Board colleagues of Hyungjin Shin
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dongwon Kim | 10176264 | Nuerepa Biotechnology Private Limited | Director |
| Sudha Kumari | 08997334 | Nuerepa Biotechnology Private Limited | Director |
| Young Sik Kim | 07505116 | Nuerepa Biotechnology Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hyungjin Shin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hyungjin Shin
Hyungjin Shin currently holds 1 directorship: Nuerepa Biotechnology Private Limited (Director, since 15 Dec 2020, revenue ₹73,835 (FY 2021)).
Hyungjin Shin was first appointed on 15 Dec 2020 as Director at Nuerepa Biotechnology Private Limited.
The current boards of Hyungjin Shin's companies include Dongwon Kim (Nuerepa Biotechnology Private Limited), Sudha Kumari (Nuerepa Biotechnology Private Limited), Young Sik Kim (Nuerepa Biotechnology Private Limited).